Porton Advanced Solutions
Suzhou
About Porton Advanced Solutions
Porton Advanced Solutions (Porton Advanced) is a CDMO specializing in Cell and Gene Therapy (CGT). To meet the therapeutic product needs of our clients at the pre-clinical, clinical, and commercial stages, we offer end-to-end process development (PD), analytical development (AD), GMP manufacturing, and testing services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $141.3M
- Funding stage: Early Stage Venture
- Last round: Series B (Aug 2022)
- Website: portonadvanced.com
- Phone: 512-88850572
Industries & Categories
Biotechnology, Genetics, Manufacturing, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/porton-advanced-solutions-106795 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.